slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 33,361-33,390
Pages 1,371
Rows per page 30
Component
33,361-33,390 of 41,127
25
2024 outlook excludes impact of M&A.ModivCare | Investor Presentation Deck | 45 slides · ModivCare
Pitch deck Investor relations Beat · Financials1 hit
31
Includes detailed debt breakdown, leverage calculations, and cash flow commentary.ModivCare | Investor Presentation Deck | 45 slides · ModivCare
Pitch deck Investor relations 1 hit
41
Contains detailed segment-level financial data (NEMT, PCS, RPM, Corporate and Other).ModivCare | Investor Presentation Deck | 45 slides · ModivCare
Pitch deck Investor relations 1 hit
45
The slide presents three distinct financial tables side-by-side, each detailing the reconciliation of GAAP net income to non-GAAP adjusted EBITDA for specific business segments.ModivCare | Investor Presentation Deck | 45 slides · ModivCare
Pitch deck Investor relations 1 hit
02
Moelis & Company | Investor Presentation Deck | 24 slidesMoelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations 1 hit
04
The slide uses a three-column layout to categorize key performance indicators and business attributes.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
02
Morgan Stanley | Investor Presentation Deck | 23 slidesMorgan Stanley | Investor Presentation Deck | 23 slides · Morgan Stanley
Conference presentation Investor relations 1 hit
03
The table uses a legend to denote 'At Scale' (check), 'Partial' (light check), and 'Limited' (dash).Morgan Stanley | Investor Presentation Deck | 23 slides · Morgan Stanley
Conference presentation Investor relations Beat · Attention1 hit
04
The slide uses a sequential process flow to show business evolution alongside asset growth milestones.Morgan Stanley | Investor Presentation Deck | 23 slides · Morgan Stanley
Conference presentation Investor relations Beat · Attention1 hit
06
The slide uses a process-oriented layout to demonstrate business growth across four distinct strategic pillars.Morgan Stanley | Investor Presentation Deck | 23 slides · Morgan Stanley
Conference presentation Investor relations Beat · Need1 hit
07
The slide uses a combination of a bar chart for historical data and a bulleted list for qualitative drivers.Morgan Stanley | Investor Presentation Deck | 23 slides · Morgan Stanley
Conference presentation Investor relations Beat · Need1 hit
08
The chart tracks rolling three-year periods, showing a consistent upward trend in net new assets.Morgan Stanley | Investor Presentation Deck | 23 slides · Morgan Stanley
Conference presentation Investor relations Beat · Need1 hit
09
The chart uses a grouped bar format to show 1H'23 vs 2H'23 performance, with a summary 'Full Year 2023' row below.Morgan Stanley | Investor Presentation Deck | 23 slides · Morgan Stanley
Conference presentation Investor relations Beat · Need1 hit
10
The slide uses a 'three-column' layout to present three distinct indicators of market cyclicality.Morgan Stanley | Investor Presentation Deck | 23 slides · Morgan Stanley
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
12
The slide uses a two-column layout to contrast current infrastructure with strategic focus areas.Morgan Stanley | Investor Presentation Deck | 23 slides · Morgan Stanley
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
15
The slide uses a before-after framing to show the evolution of AI capabilities.Morgan Stanley | Investor Presentation Deck | 23 slides · Morgan Stanley
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
16
The slide uses a waterfall-style bridge to illustrate margin expansion.Morgan Stanley | Investor Presentation Deck | 23 slides · Morgan Stanley
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
16
Includes a footnote regarding regulatory and legal matters.Nikola | Results Presentation Deck | 18 slides · Nikola
Conference presentation Investor relations 1 hit
14
The slide uses a matrix-like structure to compare drug generations against clinical outcomes.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
15
The slide uses a split-screen layout to contrast in vitro potency (dot plot) with in vivo efficacy (bar chart).Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
17
Includes detailed patient enrollment table by dose cohort and trial objectives.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
18
Data cut-off: 8 Aug 2023. Includes detailed breakdown of prior ALK TKI lines and specific mutations.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
19
Data from ALKOVE-1 Phase 1 trial, presented at AACR-NCI-EORTC 2023.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
20
The slide uses a standard oncology 'swimmer' or 'waterfall' plot format to demonstrate drug efficacy across different patient cohorts.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
23
Data cut-off: 8 Aug 2023. Source: Lin J.J. et al., AACR-NCI-EORTC 2023.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
25
The slide uses a three-column layout to segment the market by treatment line (3L+, 2L, 1L) and map the drug's value proposition to each.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
30
Slide presents three distinct preclinical data sets: IC50 viability assays, brain:plasma ratio, and selectivity index vs TRKB.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
32
Data presented in two tables: Patient Characteristics and Treatment History.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
34
Includes specific patient subgroup metrics (ORR, tumor shrinkage) and longitudinal imaging.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
06
The slide uses a circular icon-grid layout to present a set of aspirational goals.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit